Emcure Pharmaceuticals Files IPO Papers With SEBI
[email protected]08 Oct, 2021News
Bain Capital-backed Emcure Pharmaceuticals filed preliminary papers with capital markets regulator SEBI to raise funds through an initial share sale. The initial public offering comprises fresh issuance of equity shares worth ?1,100 crore and an offer of sale of over 1.8 crore (1,81,68,356) shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).
Related Bookmarks
- Egyptian athletes turn near-death experience into compelling doc that highlights the plight of refug
- Gennova�s M RNA Vaccine Gets Clearance For Phase 2/3 Clinical Trials
- Fight Against Covid-19: India's First MRNA Vaccine Phase-I Clinical Trial Gets Nod
- Gennova's Vaccine Gets Nod From DCGI To Start Phase II And Phase III Trials
- INTERVIEW: �I have a responsibility for the Arab World� says Golden Globes member Raffi Boghosian
- Pandora Papers: MGF�s Shravan Gupta owned BVI firm, JV with Emaar got $2 million
- Arab coalition intercepts Houthi ballistic missile, drones launched toward Saudi Arabia
- The best digital marketing agency in Ottawa-Top digital marketing agency in Canada
- Motorized mobile racking storage system manufacturers
- Buying Women's Replica Gucci bags Online
Recent Profiles
Personalized Property Management
Mfc Direct
Rr88
Stands Bay
Thomas Andrews/health Insurance Consulting
Fly88
Kukirin Official Website - The Best Electric Scoot
Impora Hausnotruf
Sacramento Hair Doctor
Fc Rodopa Smolyan